Este sitio web utiliza cookies para mejorar su experiencia de navegación. Más información sobre cómo usamos las cookies y cómo puede cambiar su configuración.
Reino Unido-Edimburgo: Aparatos de endoscopia y endocirugía
Anuncio de licitación
Apartado I: Poder adjudicador
Direcciones de internet:
Dirección principal: http://www.nhsscotlandprocurement.scot.nhs.uk/
Dirección del perfil de comprador: https://www.publiccontractsscotland.gov.uk/search/Search_AuthProfile.aspx?ID=AA11883
Apartado II: Objeto
The Provision of a CCE (Colon Capsule Endoscopy), Delivery, Reading and Reporting Service
The requirement for this procurement is to identify an Innovation Partner who will develop an innovative CCE (Colon Capsule Endoscopy) managed service integrated into the NHS across Scotland with the aim of improving the patient journey, improving outcomes and reducing the requirement for traditional hospital-based optical colonoscopy procedures.
The innovation partner will provide colon endoscopy capsules and a delivery, reading and reporting service to NHS Scotland.
All Health Boards within NHS Scotland
NHS Scotland is looking identify an Innovation Partner who will develop an innovative CCE (Colon Capsule Endoscopy) managed service integrated into the NHS across Scotland with the aim of improving the patient journey, improving outcomes and reducing the requirement for traditional hospital-based optical colonoscopy procedures.
Innovation Partner who will perform CCE (Colon Capsule Endoscopy), delivery, reading and reporting service including all, or some of the following components:
— patient preparation: critical for a clean and timely video and outcome,
— inform the patient, setting appointment, managing consent,
— provide patient with preparation medication and guidelines,
— assess patient’s ability to be well prepared,
— procedure delivery: - managed delivery with structured approach,
— meet the patient in their community (home, primary care centre, other health service centre),
— re-assessing ability to conduct successful procedure,
— support the patient in correct placement of belt and recorder,
— support the patient with capsule ingestion and dealing with potential adverse events,
— assist remotely when needed,
— receive returned equipment, uploading of video, managing equipment,
— video analysis: timely, save and efficient delivery of report,
— receive (de-identified) patient video,
— pre-read the video,
— validate findings,
— create comprehensive report,
— transmit report electronically to referring consultant.
In addition, in regards to IT integration, the service will be able to seamlessly refer a patient to a video capsule endoscopy and receive the report the same way as any other endoscopy report. This includes scheduling of follow-ups as well as integration into patient records such as SCI Store and with Trakcare. Users of alternative endoscopy management systems could be connected into the NHS IT infrastructure.
It will also provide a dedicated portal is available for additional status reporting and other information for patients, care takers and consultants.
The proposed Innovation Partnership will consist of two distinct phases.
Phase 1 consists of a circa 500 patient trial which will determine the clinical and economical viability of this innovative service.
Following completion of Phase 1 the Authority will either:
— terminate the agreement,
— extend into Phase 2 with no change to the agreement,
— re-negotiate a number of points with the Innovation Partner and enter into Phase 2.
Any renegotiation of the contract following phase 1 will be in line with Regulation 72 of The Public Contracts (Scotland) Regulations 2015.
Phase 2 will see the widespread adoption of the service across NHS Scotland.
— extend to the agreement,
— re-negotiate the agreement with the Innovation Partner and enter into Phase 2.
Phase 2 will see the widespread adoption of the service. The duration of Phase 1 of the contract will be 6 months.
The Authority envisages that the total contract duration will be 4 years.
See III.1.3) Technical and professional ability
It is envisaged that one (1) Innovation Partner will be awarded the contract.
Please note, the contract value given in this Contract Notice is an indicative figure. Given this is a new innovative approach the final value of the contract could vary substantially.
Apartado III: Información de carácter jurídico, económico, financiero y técnico
It is a requirement of this Innovation Partnership that bidders hold, or can commit to obtain prior to the commencement of any subsequently awarded contract, the types of insurance indicated below.
Professional Indemnity Insurance = 5 000 000 GBP.
List and brief description of selection criteria:
1) All candidates will be required to provide a statement, covering 3 previous financial years including the overall turnover of the Candidate in respect of the activities which are similar type to the subject matter of the notice;
2) All candidates will be required to provide statement of accounts or extracts relating to their business. See contract/tender documentation which incorporates the requirements of the ESPD (Scotland) and the financial period of reporting is the previous 3 years.
ESPD Question 4C.1.2 For public supply and public service contracts only, potential Innovation Partners must provide relevant examples of supplies and/or services carried out during the last 3 years which are similar to the activities described below.
The project requirement is for the provision of a CCE (Colon Capsule Endoscopy), delivery, reading and reporting service to provide an innovative Point-of-Care (PoC) investigation of the lower Gastrointestinal (GI) tract using minimally invasive CCE. The aim of this requirement is to improve the patient journey, improve patient outcomes and reduce the requirement for traditional hospital-based optical colonoscopy procedures. The Project will further test the utility of CCE, its acceptability to a wide patient cohort and models of delivery encompassing rural and urban comparison sites.
Potential Innovation Partners are invited to demonstrate, in detail, similar experience and capability of implementing innovative solutions, to a large scale, in diverse geographical areas with remote communities, in complex clinical areas such as CCE.
Additionally, potential Innovation Partners shall detail capacity in the field of research and development of developing and implementing complex clinical innovations. Potential Innovation Partners are required to demonstrate experience of handling sensitive patient data and compliance to all relevant regulations currently in place.
Question 4C.6 The following educational and professional qualifications are held by The service provider or the contractor itself:
It is a requirement that Medical Practitioners reading CCE images are:
— GMC registered,
— Hold Completion Certificate in specialist training in general medicine or general surgery,
— take part in regular medical appraisal,
— has appropriate training in reading and reporting capsule endoscopy.
It is also a requirement that nursing practitioners involved pre-reading activities are:
— registered with Nursing and Midwifery Council
— hold current re-validation certificate
— have received appropriate training in reading capsule endoscopy
Potential Innovation Partners are invited to demonstrate experience and capability of sourcing and contracting qualified Medical and Nursing Practitioners, like those highlighted above, to deliver large scale services for public or private health bodies.
It is a requirement that Medical Practitioners reading CCE images are GMC registered and hold Completion Certificate in specialist training in general medicine or general surgery.
It is also a requirement that Nursing Practitioners involved pre-reading activities are registered with Nursing and Midwifery Council and hold current re-validation certificate.
Apartado IV: Procedimiento
Apartado VI: Información complementaria
The buyer is using PCS-Tender to conduct this PQQ exercise. The Project code is 12034. For more information see: http://www.publiccontractsscotland.gov.uk/info/InfoCentre.aspx?ID=2343
A sub-contract clause has been included in this contract. For more information see: http://www.publiccontractsscotland.gov.uk/info/InfoCentre.aspx?ID=2363
Community benefits are included in this requirement. For more information see: http://www.publiccontractsscotland.gov.uk/info/InfoCentre.aspx?ID=2361
A summary of the expected community benefits has been provided as follows:
Bidders will be requested to provide details of any community benefits that will result from being awarded to the framework.
Dirección de internet: http://www.nhsscotlandprocurement.scot.nhs.uk/
The Authority will notify economic operators who submitted a tender or (where no deselection notification has previously been made) applied to be selected to tender, of its decision to award the Framework Agreement which notification will contain among other information, a summary of the reasons why the economic operators was unsuccessful. The notification will incorporate a “standstill period” of a minimum of 10 clear calendar days (or a minimum of 15 if the communication method used is not electronic) between the date on which the Authority dispatches the notice(s) and the date on which the Authority proposes to conclude the relevant Framework Agreement. The bringing of court proceedings against the Authority during the standstill period will automatically continue the prohibition on entering into the Framework Agreement until the court proceedings are determined, discontinued or disposed of, or the court, by interim order, brings to an end the prohibition. The remedies that may be awarded by the courts before the Framework Agreement has been entered into include the setting aside of the decision to award the Framework Agreement to the winning tenderer(s). The bringing of court proceedings against the Authority after the Framework Agreement has been entered into will not affect the Framework Agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise the remedies that may be awarded by the courts where the Framework Agreement has been entered into are limited to the award of damages.